Detalles de la búsqueda
1.
Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab.
Hum Vaccin Immunother
; 20(1): 2316422, 2024 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38346223
2.
Addition of quantitative MRI to the routine clinical care of patients with multiple sclerosis-Results from the MAGNON project.
Brain Behav
; 14(6): e3548, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38841819
3.
Impacts of a health literacy-informed intervention in people with chronic obstructive pulmonary disease (COPD) on hospitalization, health literacy, self-management, quality of life, and health costs - A randomized controlled trial.
Patient Educ Couns
; 123: 108220, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38458089
4.
Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod-Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC).
Vaccines (Basel)
; 11(8)2023 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37631942
5.
Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis.
Vaccines (Basel)
; 11(5)2023 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37243082
6.
Results of the gErman migraine PatIent Survey on medical Care and prOPhylactic treatment Experience (EPISCOPE).
Sci Rep
; 12(1): 4589, 2022 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35301435
7.
Assessing the immune response to SARS-CoV-2 mRNA vaccines in siponimod-treated patients: a nonrandomized controlled clinical trial (AMA-VACC).
Ther Adv Neurol Disord
; 15: 17562864221135305, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36381503
8.
Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab.
Vaccines (Basel)
; 10(12)2022 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36560576
9.
Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis.
Nat Cancer
; 2(10): 1086-1101, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35121879
10.
Defective homologous recombination DNA repair as therapeutic target in advanced chordoma.
Nat Commun
; 10(1): 1635, 2019 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30967556
Resultados
1 -
10
de 10
1
Próxima >
>>